⌕
Regencell Bioscience Holdings · RGC · Nasdaq
Tenet 30 · Weak
Compare
$4.94−3.61%At closeTenet 30 · Weak
$4.94−0.19 (−3.61%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

Regencell Bioscience Holdings (RGC) Stock

Regencell Bioscience Holdings (RGC) closed at $4.94 on Nov 13, 2026; its Tenet Score is 30 of 100 against 297 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

36 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$4.94
Nov 13, 2026
Market cap
$2.4B
share price × the latest quarter's diluted weighted-average share count (vendor)
Tenet Score
30/100
Weak · 297 Healthcare peers

Industry: Drugs

Regencell Bioscience Holdings Ltd scores 30/100. Weak. Strongest on financial health, value is the soft spot versus 297 Healthcare peers. Insufficient inputs: Tenet 30 is built from 3 of 4 pillars, from 35% of its inputs. The pillars showing a dash had no data.

Tenet Score · vs sector

n=297
30/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
1
Quality
10
Health
81
Growth
—

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Growth & Momentum omitted — no data yet.
ValueFQualityFHealthBGrowth—Momentum—
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
183.5×
price to book value
P/S
—
no P/S on file
ROE
−129%
return on equity
Operating margin
—
no operating margin on file
Net margin
—
Not meaningful: revenue is too small to measure a margin against.
Current ratio
10.77
current assets to liabilities
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file
52-wk range
—
no 52-week range on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Regencell Bioscience Holdings Ltd

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention…

Composite computed Nov 13, 2026 · peer basis: Healthcare (n=297) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 2 US ETFs · top wrappers by weightSee all ETFs holding RGC →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Regencell Bioscience Holdings in?

Regencell Bioscience Holdings is in the Healthcare sector and the Drugs industry.

What is Regencell Bioscience Holdings' Tenet Score?

Regencell Bioscience Holdings' Tenet Score is 30 out of 100, ranked against 297 Healthcare peers as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.